Provider review
VitaStir review
A printed dose ladder for both molecules, where the lowest rung costs about a third of the top.
A kit is four once-weekly injections sold as a thirty-day supply, so reordering as it runs out means thirteen purchases a year.
Reviewed by Lena OrtizMetabolic Health Editor
Price updated August 2026
How we’re funded. Some links here are affiliate links: start care through one and we may earn a commission, at no extra cost to you. Affiliate partners are listed first on our rankings — what we write about a provider is the same either way, and unflattering findings about one that pays us stay in. Full disclosure.
Price as published
VitaStir
$125/mo sema · $145/mo tirz at the lowest rung, four injections a kit
- Vs median
- $44/mo below the $169 median
- Market
- $59–$1300/mo across 242 of 373
- Structure
- Quotes off the lowest dose
- Dispensed
- Pharmacy not publicly identified
Advertising disclosure · we may earn a commission if you start care through some of these links, at no extra cost to you.
In one paragraph
The verdict
For a reader who intends to hold a deliberately small dose this is one of the more useful catalogs here, and for an unglamorous reason: the price is attached to the milligram, publicly, on both molecules, and the lowest rung is the cheapest by a wide margin. Someone holding the entry dose pays a fraction of what the maintenance rung costs, and the same shape holds for both drugs. Nothing has to be inferred, because the ladder is printed. Two features of the presentation need care. The first is the unit. A kit is four once-weekly injections and the seller calls it a thirty-day supply; four weekly doses covers twenty-eight days, so anyone reordering as they run out buys thirteen kits in a year rather than twelve, and an annual cost should be worked out from the kit rather than from the word month. The second is the discounting. Almost the whole catalog is marked as on sale, and the two struck-through figures on the weight-loss cards do not behave the way a former price should. One is struck from a number higher than any rung that ladder contains, so it is not a price the product previously carried. The other is struck from a figure that is simply the current cost of a higher dose, which makes the saving a comparison against more drug rather than against an earlier price. Both products also carry a mandatory titration notice requiring every patient to start at the lowest rung, which suits a reader starting small and says nothing about whether they may stay there.
Microdosing is off-label and unproven — decide with a clinician. Prices are as published by the provider when we last checked; confirm current terms before you buy.
Who it suits, and who it does not
A good fit if
- You want to see what your exact milligram costs before you buy anything
- You intend to hold the entry dose, where the ladder is at its cheapest by a wide margin
- You would rather buy a kit at a time than sign up to a recurring plan
Look elsewhere if
- You budget by the calendar month. A kit is four weekly injections, so a year takes thirteen
- You are measuring the advertised saving. Neither struck-through figure is a former price
- You want to start above the entry rung. Both products require beginning at the lowest
What it actually costs
Price as published
★★ Every rung priced against a named milligram, for both molecules, in a public catalog: semaglutide with B12 at $125 for 0.25 mg, $245 at 0.5 mg, $295 at 1.0 mg, $345 at 1.7 mg and $395 at 2.5 mg maintenance; tirzepatide with glycine and B12 at $145 for 2.5 mg — read on its own product page at /product/tirzepatide/, which is a separate URL from the semaglutide one and is where that whole ladder lives — $299 at 5 mg, $399 at 7.5 mg, $449 at 10 mg, $499 at 12.5 mg and $599 at 15 mg · each kit is four once-weekly injections, described by the seller as a thirty-day supply, so refills fall due every four weeks rather than every calendar month · single-dose-vial kits for both molecules are listed at $99 · the catalog card for semaglutide is struck through from $599, which is higher than every rung on its own semaglutide ladder — the ladder tops out at $395 — so that figure is not a price this product was sold at · the tirzepatide card is struck through from $399, which is the current price of its own 7.5 mg rung shown as the pre-discount price of the 2.5 mg one · both products are marked as following a mandatory titration and state that all patients must start at the lowest rung · a physician assessment is stated to be included at no additional cost · IT SELLS THE SAME MOLECULE AT TWO PRICES DEPENDING ON WHERE YOU COLLECT IT: the figures above are the mail-order home kits, and a separate in-clinic product page prices the same 2.5 mg tirzepatide starting month at $255 instead of $145 — so a reader who lands on the in-clinic page first will see a number $110 higher for what looks like the same thing, and nothing on either page points at the other
- Vs median
- $44/mo below the $169 median across the 242 of 373 programs we track that publish a plain monthly rate
- Market
- $59–$1300/mo is the full published spread in our ranking
- Structure
- Quotes off the lowest dose
States plainly that its advertised figures are based on the lowest dosage and that higher doses may cost more. On a general ranking that is a warning; for someone staying small it is the one model that bills accordingly.
36 of the 373 programs we track price a small dose this way. ★★ Every rung of both ladders is priced against a named milligram in a public catalog, and the lowest rung costs a fraction of the maintenance rung — so a reader who holds a small dose is billed for a small dose, which is the whole structure this page looks for. The billing unit is four once-weekly injections sold as a thirty-day supply, so reordering as the kit runs out means thirteen purchases in a year rather than twelve. The discounting misrepresents itself in two different ways: the semaglutide card is struck through from a figure higher than any rung that ladder contains, and the tirzepatide card is struck through from the current price of a higher dose, which makes the advertised saving a comparison against more drug rather than against an earlier price.
Microdosing is off-label and unproven — decide with a clinician. Prices are as published by the provider when we last checked; confirm current terms before you buy.
What is included
- Consult
- Included in the price
- Dietitian
- Not included
- Labs
- Not required
- Pricing
- Varies by dose, plan or tier
- Price last updated
- August 2026
What it does well
- Every rung is priced against a named milligram, for both molecules, before any intake.
- The lowest rung costs a fraction of the maintenance rung, so taking less genuinely bills less.
- A physician assessment is stated to be included at no extra charge, and lower-cost vial kits exist.
Pharmacy, labs and oversight
VitaStir does not publicly identify the pharmacy that fills its prescriptions. No bloodwork is required before you start. A clinician review is included in the price.
Transparency check
2 of 4 published openly
What VitaStir publishes about itself, read from its own pages when we verified them — not estimated, and not a score.
- Pharmacy named and regulatedNo pharmacy is identified anywhere we could find on its own pages.
- Not published
- A price you can read before intakeA monthly rate is published on its own pages — the figure in the price row above, read there and verified against it.
- Published
- What a higher dose costsPriced by dose, plan or tier, and the higher rungs are not published — the advertised figure does not tell you what a larger dose costs.
- Not published
- No FDA warning letter on fileChecked against the FDA's own warning-letter database; nothing on file for this company.
- None on file
How the program works
For a reader who intends to hold a deliberately small dose, this is one of the more useful catalogs here, and for an unglamorous reason: the price is attached to the milligram, publicly, on both molecules, and the lowest rung is the cheapest by a wide margin. Someone holding the entry semaglutide dose pays less than a third of what the maintenance rung costs, and the same shape holds for tirzepatide. Nothing has to be inferred, because the ladder is printed. Two features of the presentation need care. The first is the unit. A kit is four once-weekly injections, and the seller calls it a thirty-day supply; four weekly doses covers twenty-eight days, so anyone reordering as they run out will buy thirteen kits in a year rather than twelve, and a year's cost should be worked out from the kit rather than from the word month. The second is the discounting. Almost the whole catalog is marked as on sale, and the two struck-through figures on the weight-loss cards do not behave the way a former price should. The semaglutide card is struck from a number higher than any rung that ladder contains, so it is not a price this product previously carried. The tirzepatide card is struck from a figure that is simply the current cost of a higher dose, which makes the saving a comparison against more drug rather than against an earlier price. Both products also carry a mandatory titration notice requiring every patient to start at the lowest rung, which suits a reader starting small and says nothing about whether they may stay there.
The honest cons
A kit is four weekly injections sold as a month, so a year takes thirteen of them.
- The semaglutide card is struck through from a figure higher than any rung it charges.
- The tirzepatide saving is measured against the current price of a higher dose.
Microdosing is off-label and unproven — decide with a clinician. Prices are as published by the provider when we last checked; confirm current terms before you buy.
How it compares
VitaStir is one of 373 low-dose GLP-1 programs we track, and 242 of them publish a monthly rate you can read before signing up. The ranking lists every published price on one screen, ordered with the companies that pay us first — a mechanism we state there, on the page it applies to.
Where this sits
#233 of 373
Ordered with the companies that pay us first, and VitaStir is not one of them. A disclosed partition, not a score.
Compare all 373 providers →Read this before you buy
Intentional GLP-1 microdosing is off-label and unproven — no randomized trial has established that a sub-label dose does anything, and any dose belongs with a clinician who knows your history. If you are going to have that conversation, have it with real numbers.
- What microdosing GLP-1 costs
- Low dose vs full dose
- Titrating up from a microdose
- The true annual cost of a plan
- Microdose & reconstitution calculator
- Vial waste calculator
Microdosing is off-label and unproven — decide with a clinician. Prices are as published by the provider when we last checked; confirm current terms before you buy.
The closest alternative
Elara MD
$249/mo at 0.2 mg/wk semaglutide
- Vs median
- $80/mo above the $169 median
- Market
- $59–$1300/mo across 242 of 373
- Structure
- Quotes off the lowest dose
- Dispensed
- Compounded, 503A pharmacy
Advertising disclosure · we may earn a commission if you start care through some of these links, at no extra cost to you.
Read the Elara MD review →Microdosing is off-label and unproven — decide with a clinician. Prices are as published by the provider when we last checked; confirm current terms before you buy.